US government plans to purchase large supply of COVID-19 treatment sotrovimab for winter surge
The United States government announced plans to purchase sotrovimab, an investigational monoclonal antibody used for the early treatment of infectious-disease, according to a press release from the drugmakers, GlaxoSmithKline (GSK) plc and Vir Biotechnology, Inc. The contracts total approximately one billion dollars, according to the news release. “Given the large number of patients who continue…